Association Between Aromatase Inhibitors and Myocardial Infarction Morbidity in Women With Breast Cancer: A Meta-Analysis of Observational Studies

BACKGROUND: The cardiovascular toxicity of aromatase inhibitors (AIs) for women with estrogen receptor-positive breast cancer is controversial. We aimed to evaluate the association between AIs and the risk of myocardial infarction (MI) in women with estrogen receptor-positive breast cancer based on...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jing-Chao, Sun, Ze-Fan, He, Chao-Jie, Zhai, Chang-Lin, Qian, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647278/
https://www.ncbi.nlm.nih.gov/pubmed/36346929
http://dx.doi.org/10.1177/10732748221132512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647278/
https://www.ncbi.nlm.nih.gov/pubmed/36346929
http://dx.doi.org/10.1177/10732748221132512

Ejemplares similares